BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18802008)

  • 1. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.
    Flaumenhaft R; Dilks JR; Richardson J; Alden E; Patel-Hett SR; Battinelli E; Klement GL; Sola-Visner M; Italiano JE
    Blood; 2009 Jan; 113(5):1112-21. PubMed ID: 18802008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet- and megakaryocyte-derived microparticles.
    Flaumenhaft R; Mairuhu AT; Italiano JE
    Semin Thromb Hemost; 2010 Nov; 36(8):881-7. PubMed ID: 21049389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diversity of platelet microparticles.
    Boilard E; Duchez AC; Brisson A
    Curr Opin Hematol; 2015 Sep; 22(5):437-44. PubMed ID: 26214207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHIP-2 forms a tetrameric complex with filamin, actin, and GPIb-IX-V: localization of SHIP-2 to the activated platelet actin cytoskeleton.
    Dyson JM; Munday AD; Kong AM; Huysmans RD; Matzaris M; Layton MJ; Nandurkar HH; Berndt MC; Mitchell CA
    Blood; 2003 Aug; 102(3):940-8. PubMed ID: 12676785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived microparticles - an updated perspective.
    Siljander PR
    Thromb Res; 2011 Jan; 127 Suppl 2():S30-3. PubMed ID: 21193112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet microparticle suppressing antibody against GP Ibalpha acts independently of the filamin cleavage and increases protein tyrosine phosphorylation.
    Forestier M; Reséndiz JC; Pontiggia L; Lassila R; Beer JH
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):801-6. PubMed ID: 19002047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly.
    Jurak Begonja A; Hoffmeister KM; Hartwig JH; Falet H
    Blood; 2011 Aug; 118(8):2285-95. PubMed ID: 21652675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression.
    Yan R; Ge X; Pang N; Ye H; Yuan L; Cheng B; Zhou K; Yang M; Sun Y; Zhang S; Ding Z; Luo J; Ruan C; Dai K
    Cell Death Dis; 2021 Oct; 12(11):955. PubMed ID: 34657146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow.
    Wickenhauser C; Schmitz B; Baldus SE; Henze F; Farahmand P; Frimpong S; Thiele J; Fischer R
    Leuk Res; 2000 Dec; 24(12):1013-21. PubMed ID: 11077115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.
    Jaimes Y; Gras C; Goudeva L; Buchholz S; Eiz-Vesper B; Seltsam A; Immenschuh S; Blasczyk R; Figueiredo C
    J Thromb Haemost; 2012 Jun; 10(6):1100-8. PubMed ID: 22448926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
    Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of microparticles from platelets and megakaryocytes.
    Italiano JE; Mairuhu AT; Flaumenhaft R
    Curr Opin Hematol; 2010 Nov; 17(6):578-84. PubMed ID: 20739880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
    Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
    Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.
    Patel-Hett S; Wang H; Begonja AJ; Thon JN; Alden EC; Wandersee NJ; An X; Mohandas N; Hartwig JH; Italiano JE
    Blood; 2011 Aug; 118(6):1641-52. PubMed ID: 21566095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p.
    Qu M; Zou X; Fang F; Wang S; Xu L; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Nat Commun; 2020 Oct; 11(1):4964. PubMed ID: 33009394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.
    Italiano JE; Lecine P; Shivdasani RA; Hartwig JH
    J Cell Biol; 1999 Dec; 147(6):1299-312. PubMed ID: 10601342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.
    Choi ES; Nichol JL; Hokom MM; Hornkohl AC; Hunt P
    Blood; 1995 Jan; 85(2):402-13. PubMed ID: 7529062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosed factor V is trafficked to CD42b
    Gertz JM; McLean KC; Bouchard BA
    J Cell Physiol; 2018 Nov; 233(11):8691-8700. PubMed ID: 29761851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device.
    Six KR; Sicot G; Devloo R; Feys HB; Baruch D; Compernolle V
    Vox Sang; 2019 May; 114(4):330-339. PubMed ID: 30900265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.